Back to Awarded Treatment Trials
Awarded Trial: 13T-004
Grant ID
13T-004
Illness
schizophrenia
Primary Drug/Intervention
Spironolactone
Primary Dosage
200 mg, 400 mg
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Enrolling
Investigator
Falkai
Sample Size
81
Duration of Study Period for Each Subject
77 days
Outcome Measurements
N/A
Results
N/A
Publication
N/A
Link
N/A
PI Name
Peter Falkai
Degree
MD
Center
N/A
Institution
Ludwig-Maximilians-University
Address
NussbaumstraBe 7
City or Town
Munich
State or Province
Bavaria
Zip or Postal Code
80366
Country
Germany
Email Address
peter.falkai@med.uni-muenchen.de